Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients-Reference-Cited by-同舟云学术

Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients

Published:2018-05-10 Issue:12 Volume:53 Page:1261-1275
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Enooku Kenichiro,Kondo Mayuko,Fujiwara Naoto,Sasako Takayoshi,Shibahara Junji,Kado Akira,Okushin Kazuya,Fujinaga Hidetaka,Tsutsumi Takeya,Nakagomi Ryo,Minami Tatsuya,Sato Masaya,Nakagawa Hayato,Kondo Yuji,Asaoka Yoshinari,Tateishi Ryosuke,Ueki Kohjiro,Ikeda Hitoshi,Yoshida Haruhiko,Moriya Kyoji,Yotsuyanagi Hiroshi,Kadowaki Takashi,Fukayama Masashi,Koike Kazuhiko

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-018-1472-0/fulltext.html

Reference50 articles.

1. Bonnet F, Ducluzeau PH, Gastaldelli A, et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes. 2011;60:1660–7.

2. Bugianesi E, Moscatiello S, Ciaravella MF, et al. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des. 2010;16:1941–51.

3. Lomonaco R, Bril F, Portillo-Sanchez P, et al. Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes. Diabetes care. 2016;39:632–638.

4. Shiga T, Moriyoshi Y, Nagahara H, et al. Nonalcoholic fatty liver is a risk factor for postprandial hyperglycemia, but not for impaired fasting glucose. J Gastroenterol. 2009;44:757–64.

5. Ortiz-Lopez C, Lomonaco R, Orsak B, et al. Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care. 2012;35:873–8.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic cell junctions: Pulling a double‐duty;Liver International;2024-08-08

2. Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond;Biomedicines;2024-02-08

3. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies;Pharmacological Reviews;2024-01-30

4. A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver;2024-01-27

5. Effects of curcumin on non-alcoholic fatty liver disease: A scientific metrogy study;Phytomedicine;2024-01